These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Autoreceptor antagonists enhance the effect of the reuptake inhibitor citalopram on extracellular 5-HT: this effect persists after repeated citalopram treatment. Gundlah C; Hjorth S; Auerbach SB Neuropharmacology; 1997; 36(4-5):475-82. PubMed ID: 9225272 [TBL] [Abstract][Full Text] [Related]
8. Effects of chronic treatment with escitalopram or citalopram on extracellular 5-HT in the prefrontal cortex of rats: role of 5-HT1A receptors. Ceglia I; Acconcia S; Fracasso C; Colovic M; Caccia S; Invernizzi RW Br J Pharmacol; 2004 Jun; 142(3):469-78. PubMed ID: 15148253 [TBL] [Abstract][Full Text] [Related]
9. Effect of halving the dose of venlafaxine to adjust for putative pharmacokinetic and pharmacodynamic changes in an animal model of chronic hepatic encephalopathy. Wikell C; Kugelberg FC; Hjorth S; Apelqvist G; Bengtsson F Clin Neuropharmacol; 2001; 24(6):324-33. PubMed ID: 11801807 [TBL] [Abstract][Full Text] [Related]
10. Altered open-field behavior in experimental chronic hepatic encephalopathy after single venlafaxine and citalopram challenges. Apelqvist G; Wikell C; Hindfelt B; Bergqvist PB; Andersson G; Bengtsson F Psychopharmacology (Berl); 1999 Apr; 143(4):408-16. PubMed ID: 10367559 [TBL] [Abstract][Full Text] [Related]
11. Effect of chronic administration of the selective serotonin (5-HT) uptake inhibitor citalopram on extracellular 5-HT and apparent autoreceptor sensitivity in rat forebrain in vivo. Auerbach SB; Hjorth S Naunyn Schmiedebergs Arch Pharmacol; 1995 Dec; 352(6):597-606. PubMed ID: 9053730 [TBL] [Abstract][Full Text] [Related]
12. WAY100635-induced augmentation of the 5-HT-elevating action of citalopram: relative importance of the dose of the 5-HT1A (auto)receptor blocker versus that of the 5-HT reuptake inhibitor. Hjorth S; Westlin D; Bengtsson HJ Neuropharmacology; 1997; 36(4-5):461-5. PubMed ID: 9225270 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic and pharmacodynamic responses to chronic administration of the selective serotonin reuptake inhibitor citalopram in rats. Wikell C; Apelqvist G; Carlsson B; Hjorth S; Bergqvist PB; Kugelberg FC; Ahlner J; Bengtsson F Clin Neuropharmacol; 1999; 22(6):327-36. PubMed ID: 10626092 [TBL] [Abstract][Full Text] [Related]
14. Mechanism of action of the bimodal antidepressant vilazodone: evidence for serotonin1A-receptor-mediated auto-augmentation of extracellular serotonin output. van Amsterdam C; Seyfried CA Psychopharmacology (Berl); 2014 Jun; 231(12):2547-58. PubMed ID: 24419272 [TBL] [Abstract][Full Text] [Related]
15. The 5-HT1A receptor antagonist (S)-UH-301 augments the increase in extracellular concentrations of 5-HT in the frontal cortex produced by both acute and chronic treatment with citalopram. Arborelius L; Nomikos GG; Hertel P; Salmi P; Grillner P; Höök BB; Hacksell U; Svensson TH Naunyn Schmiedebergs Arch Pharmacol; 1996 May; 353(6):630-40. PubMed ID: 8738296 [TBL] [Abstract][Full Text] [Related]
16. Utility of organotypic raphe slice cultures to investigate the effects of sustained exposure to selective 5-HT reuptake inhibitors on 5-HT release. Nagayasu K; Yatani Y; Kitaichi M; Kitagawa Y; Shirakawa H; Nakagawa T; Kaneko S Br J Pharmacol; 2010 Dec; 161(7):1527-41. PubMed ID: 20698856 [TBL] [Abstract][Full Text] [Related]
17. Mechanistic model of acute autoinhibitory feedback action after administration of SSRIs in rats: application to escitalopram-induced effects on brain serotonin levels. Bundgaard C; Larsen F; Jørgensen M; Gabrielsson J Eur J Pharm Sci; 2006 Dec; 29(5):394-404. PubMed ID: 17014998 [TBL] [Abstract][Full Text] [Related]
18. 5-HT1A autoreceptors and the mode of action of selective serotonin reuptake inhibitors (SSRI). Hjorth S; Auerbach SB Behav Brain Res; 1996; 73(1-2):281-3. PubMed ID: 8788519 [TBL] [Abstract][Full Text] [Related]
19. Additive effect of rimonabant and citalopram on extracellular serotonin levels monitored with in vivo microdialysis in rat brain. Ortega JE; Gonzalez-Lira V; Horrillo I; Herrera-Marschitz M; Callado LF; Meana JJ Eur J Pharmacol; 2013 Jun; 709(1-3):13-9. PubMed ID: 23562616 [TBL] [Abstract][Full Text] [Related]